People: Cyanotech Corp (CYAN.OQ)

CYAN.OQ on NASDAQ Stock Exchange Capital Market

19 Jul 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cysewski, Gerald 

Dr. Gerald R. Cysewski, Ph.D. is President, Vice Chairman of the Board, Chief Scientific Officer of the Company. He was became President and Chief Executive Officer as of August 25, 2016, after having served as Interim President and Chief Executive Office beginning March 31, 2016. Prior to this he was Executive Vice President and Chief Scientific Officer. Dr. Cysewski co-founded the Company in 1983 and has served as a director of the Company since that time. From 1990 to May 16, 2008, Dr. Cysewski served as the Company’s President and Chief Executive Officer, as well as Chairman of the Board. Prior to 1990, Dr. Cysewski served in various other capacities for the Company including Vice Chairman and Scientific Director. From 1980 to 1982, Dr. Cysewski was Group Leader of Microalgae Research and Development at Battelle Northwest, a major contract research and development firm. From 1976 to 1980, Dr. Cysewski was an assistant professor in the Department of Chemical and Nuclear Engineering at the University of California, Santa Barbara, where he received a two-year grant from the National Science Foundation to develop a culture system for blue-green algae. Dr. Cysewski received his doctorate in Chemical Engineering from the University of California at Berkeley. Dr. Cysewski continues to be recognized as a leading authority on large scale production of micro-algae and is a frequently invited speaker at industry gatherings around the world, providing insight to the Board on changes in micro-algae science and regulatory matters that impact the Company. His extensive experience with the Company and his expertise in micro-algae production make him uniquely qualified to serve on our Board.

Basic Compensation

Total Annual Compensation, USD 196,101
Restricted Stock Award, USD 32,729
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 228,830

Options Compensation

  Quantity Market Value
Exercisable 4,750 --
Unexercisable 2,000 --
Exercised 11,000 24,750.00